Clinical Trials Browser

Barrett Esophagus, Carcinoma in Situ, Endometrial Hyperplasia, Fibrosis, Giant Cell Tumors, Lung Neoplasms, Osteochondroma, Carcinoma, Lobular, Nevus, Epithelioid and Spindle Cell, Hematologic Neoplasms, Non-alcoholic Fatty Liver Disease

NCT07079150 2025-07-22

Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

Recruiting

1,500 enrolled

Gastrointestinal

Bronchiolitis Obliterans Syndrome, Fibrosis, Hepatitis B, Carcinoma, Hepatocellular

NCT07036874 2025-06-29

Non-invasive Assessment for Outcome Prediction in Patients With Hepatocellular Carcinoma

Recruiting

159 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT05339984 2025-06-27

LSM

Phase NA Recruiting

150 enrolled

Fibrosis, Hypertension, Portal, Liver Diseases

NCT06864195 2025-03-07

VOCAL2

Recruiting

750 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms, Cholangitis, Sclerosing, Cholangiocarcinoma

NCT05874492 2024-12-18

FIBROTHERME

Phase NA Recruiting

110 enrolled

Breast

Breast Neoplasms, Fibrosis

NCT05797649 2024-11-13

Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)

Recruiting

120 enrolled

Thoracic

Edema, Fibrosis, Heart Failure, Infections, Neoplasms, Pleural Effusion, Tuberculosis, Hypoalbuminemia, Renal Insufficiency

NCT05637216 2024-09-03

Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

Phase 2 Recruiting

40 enrolled

Breast

Radiation Fibrosis Syndrome, Breast Neoplasms, Camurati-Engelmann Syndrome, Fibrosis, Inflammation

NCT04442334 2023-01-06

The European NAFLD Registry

Recruiting

10,000 enrolled

GastrointestinalOther

Cardiovascular Diseases, Diabetes Mellitus, Type 2, Fatty Liver, Fibrosis, Carcinoma, Hepatocellular, Hypertension, Liver Cirrhosis, Obesity, Dyslipidemias, Non-alcoholic Fatty Liver Disease

NCT05541601 2022-09-15

Pearl

Recruiting

3,000 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT04499833 2022-06-06

HepatoPredict

Phase NA Recruiting

40 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Recurrence

NCT04190849 2022-03-04

EU-PNAFLD

Recruiting

2,000 enrolled

Gastrointestinal

Diabetes Mellitus, Type 2, Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Atherosclerosis, Non-alcoholic Fatty Liver Disease

NCT04371042 2020-05-01

PROMETEO

Recruiting

5,000 enrolled

GastrointestinalOther

Diabetes Mellitus, Fatty Liver, Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms, Obesity, Metabolic Syndrome, Non-alcoholic Fatty Liver Disease

Clinical Trials

BISHOP

FASTRAK

Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention

Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis

AMULET

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]

CTMH

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

Non-invasive Assessment for Outcome Prediction in Patients With Hepatocellular Carcinoma

LSM

VOCAL2

FIBROTHERME

Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)

Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

The European NAFLD Registry

Pearl

HepatoPredict

EU-PNAFLD

PROMETEO